I don't think AS will invest any money B-UP unless our B-IBD phase 2 trial suggests we won't be effective against UP with the pill.
They still have right of first refusal on any future IBD indications (that's what they bought for $420K) so no one can snipe it out from under them. They would rather us do the DD on B-IBD before they waste a single dollar on an inferior delivery mechanism.
The recent success of the phase 1 B-IBD trial reinforces my belief in this.
Go IPIX!
Make IPIX Great Again!
Because now it looks like we were absolute geniuses for purchasing our antibiotic from bankruptcy court a year ago for $5 million." - LE